Patients taking liraglutide experienced cognitive decline 18 percent slower than those on placebo, highlighting potential Alzheimer's benefits.
Animal studies suggest GLP-1, like liraglutide, has neuroprotective effects, opening possibilities for treating Alzheimer's.
Liraglutide's potential to protect the brain, akin to how statins protect the heart, hints at groundbreaking implications for Alzheimer's treatment.
Collection
[
|
...
]